Abstract
Homogeneous HDL‐cholesterol assays have been developed and used widely in routine analysis, but they have been reported to give inaccurate results in patients with hypertriglyceridemia. Recently, a new assay based on a new principle without the influence of triglycerides has also been developed and commercialized. We evaluated the basic performance of this new homogeneous HDL‐cholesterol assay and compared it with the conventional polyethylene glycol/cyclodextrin‐modified enzyme (PEGME) method using high‐triglyceride (TG) samples (TG>8,000 mg/L). For samples showing a discrepancy with the conventional method, other precipitation and ultracentrifugation (UC) methods were also used to confirm the values. This new homogeneous assay is based on the selective solubilizing effect of detergent on the different lipoproteins. First, non‐HDL free cholesterol is consumed by enzyme and is cleared as a colorless reactant. Then. HDL‐cholesterol is selectively solubilized by lipoprotein‐specific detergent and reacted with the enzyme. As a result, the precision of this new homogeneous assay was good (CV<2%) over the wide range, and the measurement range was 0 to 2,000 mg/L. This method correlated well with the PEGME method, which is a conventional method for normolipidemic samples (y=0.97x‐3.1, r=0.994, n=424). It also correlated well with the UC method (y=0.99x+0.3, r=0.989, n=53). Fourteen high‐TG samples showed different results from those obtained by the PEGME method. Among these samples, one contained abnormal lipoproteins (probably due to the influence of drug therapy) and gave a significantly different result from that obtained by the PEGME method. However, the values obtained by other methods (precipitation and ultracentrifugation) agreed well with those obtained by this new method. In conclusion, this method shows a good basic performance and is useful for high‐TG samples without any interference. Therefore, it is considered to be very practical for a routine test. J. Clin. Lab. Anal. 17:201–208, 2003. © 2003 Wiley‐Liss, Inc.
Keywords: HDL cholesterol, selective inhibition, homogeneous assay, hypertriglyceridemia
REFERENCES
- 1. Miller GJ, Miller NE. Plasma high density lipoprotein contration and development of ischemic heart disease. Lancet 1975;1:16–23. [DOI] [PubMed] [Google Scholar]
- 2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977;62:707–714. [DOI] [PubMed] [Google Scholar]
- 3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1330–1445. [DOI] [PubMed] [Google Scholar]
- 4. Harris N, Golpchian V, Rifai N. Three routine methods for measuring high‐density lipoprotein cholesterol compared with the reference method. Clin Chem 1996;42:738–743. [PubMed] [Google Scholar]
- 5. Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of high‐density lipoprotein cholesterol in serum with polyethylene glycol modified enzymes and sulfated α‐cyclodextrin. Clin Chem 1995;41:717–723. [PubMed] [Google Scholar]
- 6. Huang YC, Kao JT, Tsai KS. Evaluation of two homogeneous methods for measuring high‐density lipoprotein cholesterol. Clin Chem 1997;43:1048–1055. [PubMed] [Google Scholar]
- 7. Okazaki M, Sasamoto K, Muramatsu T, Hosaki S. Evaluation of precipitation and direct methods for HDL‐cholesterol assay by HPLC. Clin Chem 1997;43:1885–1890. [PubMed] [Google Scholar]
- 8. Harris N, Galpchian V, Thomas J, Iannotti E, Law T, Rifai N. Three generations of high‐density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate‐Mg2+ method. Clin Chem 1997;43:816–823. [PubMed] [Google Scholar]
- 9. Simo JM, Isabel C, Natalia FJ, Jorge J, Jordi C. Evaluation of homogeneous assay for high‐density lipoprotein cholesterol: limitations in patients with cardiovascular, renal, and hepatic disorders. Clin Chem 1998;44:1233–1241. [PubMed] [Google Scholar]
- 10. Cobbaert C, Louwerens Z, Ferruccio C, et al. Reference standardization and triglyceride interference of a new homogeneous HDL‐cholesterol assay compared with a former chemical precipitation assay. Clin Chem 1998;44:779–789. [PubMed] [Google Scholar]
- 11. Rifai N, Thomas G, Elizabeth I, et al. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL‐cholesterol assay. Clin Chem 1998;44:1452–1458. [PubMed] [Google Scholar]
- 12. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low‐density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41:1414–1420. [PubMed] [Google Scholar]
- 13. Rose HD, Roth DA, Barboriak JJ. Hyperlipidemia related to miconazole therapy. Ann Intern Med 1979;91:491–492. [DOI] [PubMed] [Google Scholar]
- 14. Bagnarello AG, Lewis LA, McHenry MC, et al. Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N Engl J Med 1977;296:497–499. [DOI] [PubMed] [Google Scholar]